Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …

The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

African Americans and Latinos use services that require a doctor’s order at lower rates than
do whites. Racial bias and patient preferences contribute to disparities, but their effects …

PURPOSE To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events (irAEs) in patients treated with immune …

Purpose To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events in patients treated with immune …

… 1 , Taunton R Southwood, Prudence Manners, John Baum, David N Glass, Jose
Goldenberg, Xiaohu He, Jose Maldonado-Cocco, Javier Orozco-Alcala, Anne-Marie Prieur …

For many years a united international classification for chronic childhood arthritis has been
absent. The lack of consensus has led to difficulties in trial structure and data interpretation. …

Cancer immunotherapy has transformed the treatment of cancer. However, increasing use
of immune-based therapies, including the widely used class of agents known as immune …

OBJECTIVE: To examine the pain experience of people with hip or knee osteoarthritis (OA),
particularly changes over time and most distressing features. METHOD: Focus groups in …

Context Delirium impedes communication and contributes to symptom distress in patients
with advanced cancer. There are few prospective data on the reversal of delirium in this …